Multicenter phase II trial of motexafin gadolinium and pemetrexed for second-line treatment in patients with non-small cell lung cancer
- Martin J. Edelman
- , Gregory Otterson
- , Joseph Leach
- , Thomas Malpass
- , Ravi Salgia
- , Dennie Jones
- , Tarak D. Mody
- , Ramaswamy Govindan
Research output: Contribution to journal › Article › peer-review
14
Link opens in a new tab
Scopus
citations